263 related articles for article (PubMed ID: 28839469)
1. RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
Liu T; Li W; Lu W; Chen M; Luo M; Zhang C; Li Y; Qin G; Shi D; Xiao B; Qiu H; Yu W; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Theranostics; 2017; 7(12):3138-3154. PubMed ID: 28839469
[TBL] [Abstract][Full Text] [Related]
2. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
3. RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways.
Liu T; Wu X; Li Y; Lu W; Zheng F; Zhang C; Long Q; Qiu H; Li Y; Ge Q; Chen M; Yu X; Chen W; Zhang H; Huang W; Luo M; Deng W; Li L
Cell Physiol Biochem; 2018; 46(4):1365-1380. PubMed ID: 29689552
[TBL] [Abstract][Full Text] [Related]
4. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH
J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819
[TBL] [Abstract][Full Text] [Related]
5. RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling.
Luo C; Zhu X; Luo Q; Bu F; Huang C; Zhu J; Zhao J; Zhang W; Lin K; Hu C; Zong Z; Luo H; Huang J; Zhu Z
Front Oncol; 2020; 10():1044. PubMed ID: 32903312
[TBL] [Abstract][Full Text] [Related]
6. Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.
Zhang N; Zhang R; Zou K; Yu W; Guo W; Gao Y; Li J; Li M; Tai Y; Huang W; Song C; Deng W; Cui X
Cell Death Dis; 2017 Jul; 8(7):e2961. PubMed ID: 28749462
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L
J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.
Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C
Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630
[TBL] [Abstract][Full Text] [Related]
9. Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells.
Chen W; Lu J; Qin Y; Wang J; Tian Y; Shi D; Wang S; Xiao Y; Dai M; Liu L; Wei G; Wu T; Jin B; Xiao X; Kang TB; Huang W; Deng W
Oncotarget; 2014 Dec; 5(23):11909-23. PubMed ID: 25481043
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers.
Guo W; Lu J; Dai M; Wu T; Yu Z; Wang J; Chen W; Shi D; Yu W; Xiao Y; Yi C; Tang Z; Xu T; Xiao X; Yuan Y; Liu Q; Du G; Deng W
Oncotarget; 2014 Oct; 5(19):9349-61. PubMed ID: 25294805
[TBL] [Abstract][Full Text] [Related]
11. Melatonin inhibits MLL-rearranged leukemia via RBFOX3/hTERT and NF-κB/COX-2 signaling pathways.
Tang YL; Sun X; Huang LB; Liu XJ; Qin G; Wang LN; Zhang XL; Ke ZY; Luo JS; Liang C; Peng CJ; Tang WY; Li Y; Huang W; Luo XQ; Deng W
Cancer Lett; 2019 Feb; 443():167-178. PubMed ID: 30550850
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
[TBL] [Abstract][Full Text] [Related]
13. KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway.
Zhang C; Song C; Liu T; Tang R; Chen M; Gao F; Xiao B; Qin G; Shi F; Li W; Li Y; Fu X; Shi D; Xiao X; Kang L; Huang W; Wu X; Tang B; Deng W
Cell Death Dis; 2017 Jul; 8(7):e2940. PubMed ID: 28726783
[TBL] [Abstract][Full Text] [Related]
14. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.
Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A
BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213
[TBL] [Abstract][Full Text] [Related]
15. CDC5L Promotes hTERT Expression and Colorectal Tumor Growth.
Li J; Zhang N; Zhang R; Sun L; Yu W; Guo W; Gao Y; Li M; Liu W; Liang P; Deng W; Cui X
Cell Physiol Biochem; 2017; 41(6):2475-2488. PubMed ID: 28472785
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner.
Gai X; Zhao P; Pan Y; Shan H; Yue X; Du J; Zhang Z; Liu P; Ma H; Guo M; Yang X; Sun W; Gao L; Ma C; Liang X
Int J Biochem Cell Biol; 2013 Jul; 45(7):1174-85. PubMed ID: 23542016
[TBL] [Abstract][Full Text] [Related]
17. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
18. The NRF2-dependent transcriptional axis, XRCC5/hTERT drives tumor progression and 5-Fu insensitivity in hepatocellular carcinoma.
Liu T; Long Q; Li L; Gan H; Hu X; Long H; Yang L; Pang P; Wang S; Deng W
Mol Ther Oncolytics; 2022 Mar; 24():249-261. PubMed ID: 35071747
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.
Mizukoshi E; Nakamoto Y; Marukawa Y; Arai K; Yamashita T; Tsuji H; Kuzushima K; Takiguchi M; Kaneko S
Hepatology; 2006 Jun; 43(6):1284-94. PubMed ID: 16729333
[TBL] [Abstract][Full Text] [Related]
20. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
